CYTOTIL15
LIVE

Serial Number

99143125

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Apr 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CYTOTIL15 Trademark

Serial Number: 99143125

CYTOTIL15 is a trademark filed by Obsidian Therapeutics, Inc. on April 17, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

April 17, 2025

Registration Date

Not Registered

Published for Opposition

October 21, 2025

Goods & Services

Cells for scientific, laboratory or medical research.

Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jun 8, 2026 EX1G
SOU EXTENSION 1 FILED
Jun 8, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2025 CNSA
ASSIGNED TO EXAMINER
Sep 11, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 17, 2025 MAFR
NEW APPLICATION ENTERED
Apr 17, 2025 NWAP